Published in Fertil Steril on September 01, 1999
Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis (2011) 1.06
Positive association of sperm dysfunction in the pathogenesis of recurrent pregnancy loss. J Clin Diagn Res (2014) 0.77
Maternal exposure to sexually transmitted infections and schizophrenia among offspring. Schizophr Res (2015) 0.75
Testing for Chlamydia antibodies in recurrent spontaneous abortion. Fertil Steril (2000) 0.75
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer (2006) 6.59
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect (2002) 4.14
Chlamydia trachomatis-induced urethritis in female partners of men with nongonococcal urethritis. Sex Transm Dis (1979) 2.72
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Cross-reactivity between Chlamydiazyme and Acinetobacter strains. N Engl J Med (1986) 2.09
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet (2001) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br J Vener Dis (1978) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol (1998) 1.85
Chlamydial endometritis. J Clin Pathol (1985) 1.80
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis (1995) 1.79
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 1.69
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Chlamydia trachomatis in cervicitis and urethritis in women. Scand J Infect Dis Suppl (1982) 1.67
Single-antigen immunofluorescence test for chlamydial antibodies. J Clin Microbiol (1978) 1.66
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Portfolios as a learning tool in obstetrics and gynaecology undergraduate training. Med Educ (2001) 1.45
A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update (2002) 1.43
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer (2011) 1.41
Genital Chlamydia trachomatis infections in patients with cervical atypia. Obstet Gynecol (1979) 1.40
Examination of men with nongonococcal urethritis and their sexual partners for Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis (1979) 1.36
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol (1998) 1.33
Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am J Obstet Gynecol (1986) 1.33
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol (1986) 1.29
Mycoplasma hominis in nonspecific vaginitis. Sex Transm Dis (1984) 1.29
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology (1985) 1.29
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod (2002) 1.29
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst (1997) 1.29
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
Physiology and ecology of the vagina. Scand J Infect Dis Suppl (1983) 1.28
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J Clin Virol (2001) 1.23
Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol (1985) 1.21
Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer (1997) 1.21
Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol (2001) 1.17
Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease. J Infect Dis (1998) 1.15
Can serology diagnose upper genital tract Chlamydia trachomatis infections? Studies on women with pelvic pain, with or without chlamydial plasmid DNA in endometrial biopsy tissue. Sex Transm Dis (1998) 1.13
Isolation and sequence analysis of the Chlamydia pneumoniae GroE operon. Infect Immun (1991) 1.11
Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol (1985) 1.10
First-void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women. Sex Transm Dis (1997) 1.10
Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Ultrasound Obstet Gynecol (2002) 1.10
MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology (1999) 1.10
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
Infertility treatment and marital relationships: a 1-year prospective study among successfully treated ART couples and their controls. Hum Reprod (2007) 1.09
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med (1997) 1.08
Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) (1999) 1.08
The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Methods (2000) 1.06
Natural history of vaginal intraepithelial neoplasia. Cancer (1991) 1.06
Serological evidence for the role of Bacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease. Lancet (1981) 1.06
A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res (1997) 1.05
Cytologic findings in cervical chlamydial infection. Med Biol (1980) 1.03
Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03
Colposcopic and histologic findings in cervical chlamydial infection. Obstet Gynecol (1982) 1.02
Infertility following pelvic inflammatory disease. Infect Dis Obstet Gynecol (1999) 1.02
Association of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis syndrome. J Infect Dis (1981) 1.02
Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility. Hum Reprod (2006) 1.02
Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect (1996) 1.00
Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 0.99
The incidence of preterm deliveries decreases in Finland. BJOG (2008) 0.99
Chlamydial infections. Microbiological, clinical and diagnostic aspects. Med Biol (1979) 0.99
VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod (2000) 0.99
Chlamydial pneumonitis and its serodiagnosis in infants. J Infect Dis (1984) 0.98
Chlamydia trachomatis as a possible cause of peritonitis and perihepatitis in a young woman. Br J Vener Dis (1980) 0.98
Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol (2000) 0.98
Chlamydia trachomatis detected in human placenta. J Clin Pathol (1997) 0.98
Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol (1992) 0.98
Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS (2000) 0.97
Chlamydia trachomatis in acute salpingitis. Am J Obstet Gynecol (1980) 0.97
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer (1999) 0.97
The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24. J Eur Acad Dermatol Venereol (2009) 0.95
Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer (1996) 0.95
CCN activity and hygroscopic growth of organic aerosols following reactive uptake of ammonia. Environ Sci Technol (2008) 0.95
Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J Infect Dis (2009) 0.95
Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay. Infect Dis Obstet Gynecol (1997) 0.95
Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci (2001) 0.93
Colposcopic and histological findings in cervical chlamydial infection. Lancet (1980) 0.93
Observer variability in the scoring of colpophotographs. Obstet Gynecol (1990) 0.93
Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis (1998) 0.93
Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol (1997) 0.92
Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women. Clin Exp Immunol (2003) 0.92
Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 0.92
Antigen specific serum antibody response to Chlamydia trachomatis in patients with acute pelvic inflammatory disease. J Clin Pathol (1990) 0.92
Erythromycin and lymecycline treatment in chlamydia-positive and Chlamydia-negative non-gonococcal urethritis--a partner-controlled study. Acta Derm Venereol (1979) 0.91